DEALE-ing with lung cancer and heart failure

Medical Decision Making

Volumn 25, Issue 1, 2005, Pages 82-94

  Sondhi, Manu ^a   Coffin, John R ^a   Cohen, Brian J ^a   Wong, John B ^a   Pauker, Stephen G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARDIOMYOPATHY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CORONARY ARTERY BYPASS SURGERY; CORONARY VESSEL MALFORMATION; DEFIBRILLATOR; HEART ARREST; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; MEDICAL DECISION MAKING; NEEDLE BIOPSY; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; QUALITY OF LIFE; REVIEW; SURGICAL MORTALITY; SURVIVAL RATE; THORAX RADIOGRAPHY; TUMOR VOLUME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARDIAC OUTPUT, LOW; DECISION TREES; HUMANS; LIFE TABLES; LUNG NEOPLASMS; MALE; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 12344295427     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X05274523     Document Type: Review

References (32)

1. Beck JR, Pauker SG, Gottlieb JE, Klein K, Kassirer JP. A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. Am J Med. 1982;73(6):889-97.
2. Beck JR, Kassirer JP, Pauker SG. A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med. 1982;73(6):883-8.
3. Arias E. National Vital Statistics Report, Vol. 52, No. 14. United States Life Tables, 2001. Hyattsville (MD): National Center for Health Statistics; 2004.
4. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107(23):2920-5.
5. Nohria A, Tsang SW, Fang JC, et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure [see Comment]. J Am Coll Cardiol. 2004;41(10):1797-804.
6. Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362(9377):7-13.
7. Johnson D, Jin Y, Quan H, Cujec B. Beta-blockers and angiotensin- converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada. J Am Coll Cardiol. 2004;42(8):1438-45.
8. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290(19):2581-7.
9. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877-83.
10. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335(26):1933-40.
11. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronaryartery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med. 1997;337(22):1569-75.
12. Mountain CF. The international system for staging lung cancer. Semin Surg Oncol. 2000;18(2):106-15.
13. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60(3):615-22.
14. Port JL, Kent MS, Korst RJ, Libby D, Pasmantier M, Altorki NK. Tumor size predicts survival within stage IA non-small cell lung cancer. Chest. 2004;124(5):1828-33.
15. Ambrogi V, Pompeo E, Elia S, Pistolese GR, Mineo TC. The impact of cardiovascular comorbidity on the outcome of surgery for stage I and II non-small-cell lung cancer [see Comment]. Eur J Cardio Thorac Surg. 2003;23(5):811-7.
16. Okada M, Nishio W, Sakamoto T, et al. Evolution of surgical outcomes for non-small cell lung cancer: time trends in 1465 consecutive patients undergoing complete resection. Ann Thorac Surg. 2004;77(6):1926-30.
17. Keller SM, Vangel MG, Wagner H, et al. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. J Thorac Cardiovasc Surg. 2004;128(1):130-7.
18. Walker WS, Codispoti M, Soon SY, Stamenkovic S, Carnochan F, Pugh G. Long-term outcomes following VATS lobectomy for non-small cell bronchogenic carcinoma. Eur J Cardio Thorac Surg. 2003;23(3):397-402.
19. Sugi K, Kaneda Y, Esato K. Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer. World J Surg. 2000;24(1):27-30.
20. Chang MY, Sugarbaker DJ. Surgery for early stage non-small cell lung cancer. Semin Surg Oncol. 2003;21(2):74-84.
21. Cheung PC, Mackillop WJ, Dixon P, Brundage MD, Youssef YM, Zhou S. Involved-field radiotherapy alone for early-stage non-smallcell lung cancer. Int J Radiat Oncol Biol Phys. 2000;48(3):703-10.
22. Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax. 2001;56(8):628-38.
23. McGarry RC, Song G, des Rosiers P, Timmerman R. Observation-only management of early stage, medically inoperable lung cancer: poor outcome. Chest. 2002;121(4):1155-8.
24. Chadha AS, Sohi JS, Sahmoun AE, Alshehadat S, Mehdi S. Survival in untreated early non-small cell lung cancer: a retrospective analysis (abstract). Society of Surgical Oncology 2004.
25. Daniels LJ, Balderson SS, Onaitis MW, D'Amico TA. Thoracoscopic lobectomy: a safe and effective strategy for patients with stage I lung cancer. Ann Thorac Surg. 2002;74(3):860-4.
26. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977;297(16):845-50.
27. van den Hout WB, Houwelingen JCV, Noordijk EM, Kramer GWPM, Leer JWH. Extrapolating utility and cost data in terminally ill patients: a pragmatic modeling approach (abstract). Presented at the annual meeting of the Society for Medical Decision Making; 2004 Oct 17-20; Atlanta, GA.
28. Keeney RL, Raiffa H. Decisions with Multiple Objectives: Preferences and Value Tradeoffs [Wiley Series in Probability and Mathematical Statistics]. New York: John Wiley; 1976.
29. National Cancer Institute. Surveillance, Epidemiology, and End Results Program (SEER) US Population Data-1969-2000. Washington (DC): National Cancer Institute; 2004.
30. Durand-Zaleski I, Zaleski S. DEALE-ing and discounting: a simple way to compute the accrued costs of preventive strategies. Med Decis Making. 1994;14(1):98-103.
31. von Neumann J, Morgenstern O. Theory of Games and Economic Behavior 3rd ed. Princeton (NJ): Princeton University Press; 1953.
32. Cohen BJ. Is expected utility theory normative for medical decision making? Med Decis Making. 1996;16(1):1-6.